InvestorsHub Logo
Followers 17
Posts 1161
Boards Moderated 0
Alias Born 04/17/2013

Re: stangish post# 4985

Wednesday, 04/24/2013 4:28:25 PM

Wednesday, April 24, 2013 4:28:25 PM

Post# of 426858
I believe what you're referring to was whether the ANCHOR approval was linked to the outcome of the Reduce-It study. Agreed, they're not at all linked.

This is stating something else:

NCE will happen even if FDA has to change rules, they would have not asked for Reduce-it if generics could be on market at same time
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News